Latest database descriptions

Evaluate the observance of the adjuvant treatment with Taxotere® in the operable breast cancer that has spread to the lymph nodes.

Evaluate the relevance of new biomarkers for monitoring allergic bronchopulmonary aspergillosis : study of changes in exhaled NO, induced sputum cellularity, Aspergillus serology by ELISA method lymphocyte populations.

Objectives of the registry in terms of public health (surveillance, evaluation):
1) listing of all cases of hematological malignancies occurring in a well-defined population so as to
provide the health and social authorities with precise data regarding the incidence, breakdown
per gender, age range, geographical zone and socioprofessional category of these
diseases;
2) recording of data on these cases makes it possible to evaluate different characteristics such as
the stage of diagnosis, elements of the diagnosis and cancer staging report, therapy
and survival;
3) a role to alert the public authorities in the rapid rise in incidence of certain pathologies and
in the identification of the cause of this rise;
4) a role in improving the quality of data on hematological malignancies in the
general cancer registries.
- Objectives of the registry in terms of research;
1) in etiological epidemiology with the detection of environmental,
personal and family risk factors of hematological malignancies;
2) in molecular epidemiology with the development of genetic or epigenetic research,
3) in pharmacological epidemiology with the development of therapies, their setting up, access to
new therapies and their effect at population level on patient survival, the quality
of this survival and the distant consequences of their use;
4) setup of tumor tissue collection

General objective - To estimate the incidence of LONIPC: Late-onset non-infectious pulmonary complications - To characterise clinical and radiological aspects as well as initial and progressive respiratory function - To investigate factors leading to occurrence Secondary objective: - To estimate the incidence of LONIPC in HSCT (hematopoietic stem cell transplantation) on an unselected prospective cohort to allow a multi-centric prospective prognostic cohort study with satisfactory statistical power